Kymera Therapeutics, Inc.KYMRNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-859.48%
↓ 2752% below average
Average (24q)
32.41%
Historical baseline
Range
High:912.80%
Low:-859.48%
Volatility
5468.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -859.48% |
| Q2 2025 | -57.50% |
| Q1 2025 | 198.89% |
| Q4 2024 | 97.65% |
| Q3 2024 | -85.42% |
| Q2 2024 | 149.34% |
| Q1 2024 | -78.52% |
| Q4 2023 | 912.80% |
| Q3 2023 | -71.37% |
| Q2 2023 | 74.45% |
| Q1 2023 | -41.35% |
| Q4 2022 | 68.98% |
| Q3 2022 | -17.05% |
| Q2 2022 | 19.66% |
| Q1 2022 | -37.01% |
| Q4 2021 | -24.89% |
| Q3 2021 | 9.81% |
| Q2 2021 | -0.98% |
| Q1 2021 | 46.28% |
| Q4 2020 | -12.03% |
| Q3 2020 | 342.00% |
| Q2 2020 | -4.08% |
| Q1 2020 | 87.02% |
| Q4 2019 | 92.95% |
| Q3 2019 | 0.00% |